Xianghui Han

Title: Innovations of Xianghui Han in Anti-HBV Pharmaceutical Development

Introduction

Xianghui Han is a notable inventor based in Weifang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-HBV (hepatitis B virus) treatments. His innovative work has the potential to impact the lives of many individuals affected by this virus.

Latest Patents

Xianghui Han holds a patent for a sulfonamide benzamide derivative, which is a promising pharmaceutical composition for combating HBV. The patent describes a preparation method that involves sulfonation, acylation, and sulfonylation reactions. This sulfonamide benzamide derivative has demonstrated effective activity against HBV by inhibiting HBV DNA replication in vitro. He has 1 patent to his name, showcasing his dedication to advancing medical science.

Career Highlights

Xianghui Han is affiliated with Weifang Medical University, where he contributes to research and development in the medical field. His work focuses on creating effective treatments for viral infections, particularly hepatitis B. His research efforts are aimed at improving patient outcomes and enhancing the quality of life for those affected by HBV.

Collaborations

Xianghui Han collaborates with esteemed colleagues, including Haiyong Jia and Chuanju Li. Together, they work on innovative projects that aim to push the boundaries of pharmaceutical research and development.

Conclusion

Xianghui Han's contributions to the field of anti-HBV pharmaceuticals highlight his commitment to innovation and research. His work not only advances scientific knowledge but also holds the promise of improving health outcomes for patients worldwide.